Abstract
The homozygous deletion allele of the angiotensin-converting enzyme gene (ACE/DD), homozygous threonine allele of the angiotensinogen gene (AGN/TT), and the ɛ4 allele of the apolipoprotein E gene (apoE/ɛ4) are reported to be associated with ischemic heart disease. Cerebral infarction (CI) is another atherosclerotic disease, and the effects of these polymorphisms on CI have been confusing. The frequency of the DD genotype of the ACE gene, but not the TT genotype of the AGN gene and the ɛ4 allele of ApoE, was significantly higher in subjects with than those without CI in Japan. In this study, we investigated whether ACE/DD, AGN/TT, and apoE/ɛ4 genotypes are associated with CI and whether genetic risk is enhanced by the effect of one upon another. We ascertained these genotypes in patients with CI (n=365), diagnosed by brain computed tomography. Control subjects for the infarction group were randomly selected from 319 subjects matched for age, gender, and history of hypertension with patients. The ACE/DD genotype was not associated with CI. Frequency of the AGN/TT genotype was higher in patients with CI than in controls (x2=12.287, p<0.05). The frequency of t allele was 0.88 in patients and 0.82 in controls (x 2=11.041, p<0.05; odds ratio, 1.7). Furthermore, the AGN/TT genotype increased the relative risk for CI in subjects with the ACE/DD genotype (x 2=7.8, p<0.05; odds ratio, 1.9). There was no significant association between apoE/ɛ4 and CI. These results suggest that AGN/TT predicts CI and ACE/DD enhances the risk for CI associated with AGN/TT in a Korean population.
Similar content being viewed by others
References
Barley J., Markus H., Brown M., and Carter N. (1995) Lack of association between angiotensinogen polymorphism (M235T) and cerebrovascular disease and carotid atheroma. J. Hum. Hypertens. 9, 681–683.
Batalla A., Alvarez R., Reguero J. R., Hevia S., Iglesias-Cubero G., Alvarez V., et al. (2000) Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction. Clin. Chem. 46, 1910–1915.
Cambien F., Poirier O., Lecerf L., Evans A., Cambou J. P., Arveiler D., et al. (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359, 641–644.
Carluccio M., Soccio M., and De Caterina R. (2001) Aspects of gene polymorphisms in cardiovascular disease: the renin-angiotensin system. Eur. J. Clin. Invest. 31, 476–488.
Corbo R. M., Scacchi R., Vilardo T., and Ruggeri M. (2001) Polymorphisms in the apolipoprotein E gene regulatory region in relation to coronary heart disease and their effect on plasma apolipoprotein E. Clin. Chem. Lab. Med. 39, 2–6.
Coria F., Rubio I., Nunez E., Sempere A. P., SantaEngarcia N., Bayon C., et al. (1995) Apolipoprotein E variants in ischemic stroke. Stroke 26, 2375–2376.
Costerousse O., Allegrini J., Lopez M., and Alhenc-Gelas F. (1993) Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem. J. 290, 33–40.
Danser A. H., Schalekamp M. A., Bax W. A., van den Brink A. M., Saxena P. R., Riegger G. A., et al. (1995) Angiotensin-converting enzyme in human heart. Effect of the deletion/insertion polymorphism. Circulation 92, 1387–1388.
Davignon J., Gregg R. E., and Sing C. F. (1988) Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 8, 1–21.
Evans A. E., Poirier O., Kee F., Lecerf L., McCrum E., Falconer T., et al. (1994) Polymorphisms of the angiotensin-converting enzyme gene in subjects who die from coronary heart disease. Q. J. Med. 87, 211–214.
Fernandez-Arcas N., Dieguez-Lucena J. L., Munoz-Moran E., Ruiz-Galdon M., Espinosa-Caliani S., Aranda-Lara P., et al. (2001) Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infarction. Clin. Genet. 60, 52–57.
Hachinski V., Graffagnino C., Beaudry M., Bernier G., Buck C., Donner A., et al. (1996) Lipids and stroke: a paradox resolved. Arch. Neurol. 53, 303–308.
Hixson J. E. (1991) Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler. Thromb. 11, 1237–1244.
Hixson J. E. and Vernier D. T. (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31, 545–548.
Hooper W. C., Dowling N. F., Wenger N. K., Dilley A., Ellingsen D., and Evatt B. L. (2002) Relationship of venous thromboembolism and myocardial infarction with the renin-angiotensin system in African-Americans. Am. J. Hematol. 70, 1–8.
Jeron A., Hengstenberg C., Engel S., Lowel H., Riegger G. A., Schunkert H., et al. (2001) The D-allele of the ACE polymorphism is related to increased QT dispersion in 609 patients after myocardial infarction. Eur. Heart J. 22, 663–668.
Jeunemaitre X., Soubrier F., Kotelevtsev Y. V., Lifton R. P., Williams C. S., Charru A., et al. (1992) Molecular basis of human hypertension: role of angiotensinogen. Cell 71, 169–180.
Kamitani A., Rakugi H., Higaki J., Yi Z., Mikami H., Miki T., et al. (1994) Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J. Hum. Hypertens. 8, 521–524.
Katsuya T., Koike G., Yee T. W., Sharpe N., Jackson R., Norton R., et al. (1995) Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 345, 1600–1603.
Kessler C., Spitzer C., Stauske D., Mende S., Stadlmuller J., Walther R., et al. (1997) The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler. Thromb. Vasc. Biol. 17, 2880–2884.
Lehtinen S., Lehtimaki T., Sisto T., Salenius J. P., Nikkila M., Jokela H., et al. (1995) Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis 114, 83–91.
Luc G., Bard J. M., Arveiler D., Evans A., Cambou J. P., Bingham A., et al. (1994) Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler. Thromb. 14, 1412–1419.
MacLeod M. J., De Lange R. P., Breen G., Meiklejohn D., Lemmon H., and Clair D. S. (2001) Lack of association between apolipoprotein E genoype and ischaemic stroke in a Scottish population. Eur. J. Clin. Invest. 31, 570–573.
Margaglione M., Seripa D., Gravina C., Grandone E., Vecchione G., Cappucci G., et al. (1998) Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian case-control study. Stroke 29, 399–403.
Marshall H. W., Morrison L. C., Wu L. L., Anderson J. L., Corneli P. S., Stauffer D. M., et al. (1994) Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study. Circulation 89, 567–577.
Miller S. A., Dykes D. D., and Polesky H. F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215.
Nakata Y., Katsuya T., Rakugi H., Takami S., Ohishi M., Kamino K., et al. (1996) Polymorphism of the apolipoprotein E and angiotensin-converting enzyme genes in Japanese subjects with silent myocardial ischemia. Hypertension 27, 1205–1209.
Nakata Y., Katsuya T., Rakugi H., Takami S., Sato N., Kamide K., et al. (1997) Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease. Am. J. Hypertens. 10, 1391–1395.
Pedro-Botet J., Senti M., Nogues X., Rubies-Prat J., Roquer J., D’Olhaberriague L., et al. (1992) Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein (a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 23, 1556–1562.
Peng D. Q., Zhao S. P., and Wang J. L. (1999) Lipoprotein (a) and apolipoprotein E epsilon 4 as independent risk factors for ischemic stroke. J. Cardiovasc. Risk 6, 1–6.
Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., and Soubrier F. (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86, 1343–1346.
Russ A. P., Maerz W., Ruzicka V., Stein U., and Gross W. (1993) Rapid detection of the hypertension-associated Met235→Thr allele of the human angiotensinogen gene. Hum. Mol. Genet. 2, 609–610.
Samani N. J., Thompson J. R., O’Toole L., Channer K., and Woods K. L. (1996) A meta-analysis of the association of the deletion allele of the angiotensin converting enzyme gene with myocardial infarction. Circulation 94, 708–712.
Saunders A. M. and Roses A. D. (1993) Apolipoprotein E4 allele frequency, ischemic cerebrovascular disease, and Alzheimer’s disease. Stroke 24, 1416.
Staessen J. A., Kuznetsova T., Wang J. G., Emelianov D., Vlietinck R., and Fagard R. (1999) M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J. Hypertens. 17, 9–17.
Stengard J. H., Zerba K. E., Pekkanen J., Ehnholm C., Nissinen A., and Sing C. F. (1995) Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 91, 265–269.
Tiret L., de Knijff P., Menzel H. J., Ehnholm C., Nicaud V., and Havekes L. M. (1994) ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. European Atherosclerosis Research Study. Arterioscler. Thromb. 14, 1617–1624.
Um J. Y., Kim H. J., Choi T. J., Jin C. S., Park S. T., Lee K. C., et al. (2001) Polymorphism of the angiotensin-converting enzyme gene in patients with cerebral infarction in Koreans. J. Mol. Neurosci. 17, 279–283.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Um, JY., Moon, KS., Lee, KM. et al. Polymorphism of angiotensin-converting enzyme, angiotensinogen, and apolipoprotein E genes in Korean patients with cerebral infarction. J Mol Neurosci 21, 23–28 (2003). https://doi.org/10.1385/JMN:21:1:23
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:21:1:23